Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...
In the realm of genetic engineering and biotechnology, the creation of hybrid animals—organisms that combine genetic material ...
Yet in the not-so-distant past, Shapiro didn’t see why the dodo needed to make a comeback. Like many skeptics of the idea of ...